Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Police Raid Suizo Argentina and Disability Agency in Explosive Graft Probe Tied to Milei's Sister

Argentine President Javier Milei's sister, Karina Milei, is accused of taking a 3% cut in a Suizo Argentina pharmaceutical deal with the National Disability Agency. Police raids, leaked recordings, and election-year tensions intensify the scandal.

Latin Times

Singapore is worried about a rise in drug-laced vaping. What is happening, and what is the drug etomidate?

Vaping has been banned since 2018, but now authorities are seeing a rise in young people using them to take an anaesthetic agent

The Guardian - AU

FDA Approves Biogen, Eisai's Highly Anticipated Alzheimer's Treatment

Biogen and Eisai won Food and Drug Administration approval of an at-home shot version of their Alzheimer's treatment Leqembi.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Who is Jim O’Neill? CDC chief set to bolster RFK Jr plan to remake vaccine policy

Ally of health secretary worked as speechwriter in George W Bush administration and has no training in medicine

The Guardian - US

FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk

The FDA signed off on the first-ever weight-loss generic on Thursday, a knockoff of Novo Nordisk's Saxenda from Teva Pharmaceutical.

Investors Business Daily

Travere Flirts With A Breakout As FDA Decision Bolsters Filspari's Launch

Travere Therapeutics shares rose Thursday after the FDA altered monitoring requirements for its drug, Filspari.

Investors Business Daily

Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure

Novo Nordisk stock remains under pressure this year. But the company is now launching Wegovy in MASH treatment. Can it make a comeback?

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Mounjaro maker pauses shipments of weight loss drug to UK

US firm Eli Lilly reportedly tells British wholesalers to stop taking orders as demand soars before September price rise

The Guardian - UK

Mounjaro weight loss jab sales are halted in the UK as drugmaker looks to beat price rise

Eli Lilly, the manufacturer of Mounjaro, has temporarily suspended deliveries of the drug to UK pharmacies in response to ‘unprecedented demand’

Evening Standard

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.

BioNTech stock skidded Wednesday after the Food and Drug Administration ended its broad authorization of Covid vaccines in the U.S.

Investors Business Daily

Texas Legislature approves bill making ivermectin an over-the-counter drug

Some people use the drug to treat COVID, even though it’s not approved by the FDA for such use. The bill now awaits the governor’s signature.

The Texas Tribune

Tough talk from Streeting – but he still needs a deal with big pharma

Health secretary calls industry ‘shortsighted’ but there is danger in giving UK better terms than much of rich Europe

The Guardian - UK

Pharmacists ‘using personal finances and remortgaging to keep businesses afloat’

It comes as a survey found almost four in 10 pharmacies are unable to pay bills for medication on time.

Evening Standard

Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win

Gilead Sciences won European approval Tuesday for its new twice-annual HIV prevention shot, now called Yeytuo.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted

Shares of Axogen plunged Monday after the FDA delayed the expected approval date for the company's nerve graft product.

Investors Business Daily

Argenx Tops Buy Point On Bullish Study, 850 Price Target

Argenx announced positive study results and plans to seek FDA approval to expand its label for Vyvgart.

Evening Standard

Streeting vows not to let drug firms ‘rip off’ taxpayers after pricing row

The Health Secretary on Friday left talks with the pharmaceuticals sector after both sides failed to agree changes to a drug pricing deal.

The Guardian - UK

Wes Streeting criticises ‘shortsighted’ drug firms for rejecting pricing offer

Exclusive: Health secretary says he will not let patients be ‘ripped off’ by pharmaceutical companies amid standoff

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

What is the row between Wes Streeting and pharmaceutical companies about?

Health secretary has accused firms of being ‘shortsighted’ during dispute over terms for provision of drugs to the NHS

International Business Times

Breaking the Bottleneck: How Verseon is Rewriting the Future of Drug Discovery Beyond Pharma's Limits

Verseon is transforming drug discovery with physics-based design, breaking pharma's limits to deliver safer, faster treatments across major diseases.

International Business Times UK

Fury as Tech CEO Sues Uber After Being Assaulted by Illegal Immigrant Driver — Then Losing His Account

Biotech CEO Bryan Kobel sues Uber after allegedly being brutally assaulted by an undocumented Uber driver who denied his service dog, leaving him with serious injuries and prompting scrutiny of Uber's driver vetting.

Investors Business Daily

Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?

Biohaven stock surged Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, troriluzole.

The Guardian - UK

Wes Streeting’s row with pharma firms grows as they reject NHS drug pricing offer

Drugmakers reject health secretary’s latest offer, meaning ‘unsustainable’ rebate scheme will stay in place

Investors Business Daily

Low Volatility Calls For This Breakout Trade On Pfizer Stock

Pfizer stock currently trades at very low volatility. That could mean it’s ripe for a breakout trade, like a long strangle.

Investors Business Daily

Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug

Gilead stock toppled Thursday on a report CVS won't add the company's new HIV prevention drug, Yeztugo, to its commercial plans for now.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the Food and Drug Administration

196 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.